STERIS (STE) reported fiscal Q1 adjusted earnings late Wednesday of $2.59 per diluted share, up from $2.34 a year ago.

Analysts polled by FactSet expected $2.50.

Revenue for the three months ended June 30 rose to $1.5 billion from $1.4 billion a year earlier.

Analysts expected $1.5 billion.

For fiscal 2027, the firm reaffirmed adjusted EPS guidance of $11.10 to $11.30. Analysts expect $11.16.